Status:
COMPLETED
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The purpose of this study is to see if the cells in rectal cancer are oxygen-starved, or hypoxic. We know that as cancers grow bigger, parts of them are cut off from the oxygen supply and they become ...
Eligibility Criteria
Inclusion
- Biopsy proven adenocarcinoma of the rectum. If a biopsy was taken at an outside hospital, the slides and diagnosis will be reviewed and confirmed by a pathologist at MSKCC.
- Mid to distal rectal tumors not requiring pre-op radiation or chemotherapy
- Age ≥ 18
- Age \< 90
- Karnofsky performance status ≥ 60
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Current pregnancy
- Uncontrolled intercurrent illness that would limit compliance with study requirements.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01189877
Start Date
August 1 2010
End Date
October 1 2012
Last Update
October 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065